Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2006-000947-24Phase 4Unknown
Phase 4, randomised trial of beclomethasone dipropionate in allergic rhinitis (AR) (2 arms), sponsored by Peterborough and Stamford Hospitals NHS Foundation Trust. Primary endpoint: recurrence of allergic rhinitis. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2006-000947-24.